Insider · CIK 0002117599
William Todd Horich
Files at SUPN (SUPERNUS PHARMACEUTICALS, INC.). First filing Mar 10, 2026, latest Mar 10, 2026.
In brief
William Todd Horich files SEC Form 4 as officer at SUPN (SUPERNUS PHARMACEUTICALS, INC.). Since Mar 10, 2026, William Todd Horich has reported 0 open-market buys worth $0 and 1 open-market sell worth $484k, the latest filed on Mar 10, 2026.
A track record needs three past buys with six months of prices behind them; William Todd Horich has 0, so none is measured yet.
The newest scored trade: sold $484k of SUPN on Mar 9, 2026, filed Mar 10, 2026, scored 53 (moderate). In the last 12 months: 0 buys worth $0 and 1 sell worth $484k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
SUPN: SUPERNUS PHARMACEUTICALS, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 53Moderate | SUPERNUS PHARMACEUTICALS, INC. | $484k 8,877 shares | -100% | +79% from low-5% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Mar 10, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | 4,439 0.01% of outstanding | $244k | Mar 10, 2026 | $240k |
| Mar 9, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | 4,438 0.01% of outstanding | $240k | Mar 9, 2026 | none |
Transactions
Every row this insider has filed, 11 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 6, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | MOption exercise Common Stock | +2,625 | $0.00 | $0 | 7,457 | Mar 10, 2026 |
| Mar 6, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | FTax withholding Common Stock | -1,216 | $54.73 | $67k | 6,241 | Mar 10, 2026 |
| Mar 6, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | MOption exercise Common Stock | +3,750 | $0.00 | $0 | 9,991 | Mar 10, 2026 |
| Mar 6, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | FTax withholding Common Stock | -1,718 | $54.73 | $94k | 8,273 | Mar 10, 2026 |
| Mar 6, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | MOption exercise Common Stock | +1,125 | $0.00 | $0 | 9,398 | Mar 10, 2026 |
| Mar 6, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | FTax withholding Common Stock | -521 | $54.73 | $29k | 8,877 | Mar 10, 2026 |
| Mar 9, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -4,438 | $54.00 | $240k | 4,439 | Mar 10, 2026 |
| Mar 10, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -4,439 | $55.00 | $244k | 0 | Mar 10, 2026 |
| Mar 6, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | MOption exercise Performance Share Unitderivative | -2,625 | $0.00 | $0 | 0 | Mar 10, 2026 |
| Mar 6, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | MOption exercise Performance Share Unitderivative | -3,750 | $0.00 | $0 | 0 | Mar 10, 2026 |
| Mar 6, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | MOption exercise Performance Share Unitderivative | -1,125 | $0.00 | $0 | 0 | Mar 10, 2026 |
Questions about William Todd Horich
Answered from the filings on this page, as of the latest one.
Is William Todd Horich buying or selling?
In the last 12 months William Todd Horich reported 0 open-market buys worth $0 and 1 open-market sell worth $484k on SEC Form 4; the latest was sold $484k of SUPN on Mar 9, 2026. Grants, option exercises and tax withholding are not counted.
How did William Todd Horich's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and William Todd Horich has 0.
Where does William Todd Horich file Form 4?
William Todd Horich has filed Form 4 at SUPN (SUPERNUS PHARMACEUTICALS, INC.) as SVP, Commercial Operations. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.